Purdue Pharma Seeks To Halt Opioid Suits With Ch. 11 Filing

Law360 (September 16, 2019, 7:28 AM EDT) -- OxyContin maker Purdue Pharma LP filed for Chapter 11 protection in New York late Sunday night, less than a week after reaching a deal to settle more than 2,000 suits by local governments, states and tribes over its alleged role in fueling the opioid crisis.

Stamford, Connecticut-based Purdue Pharma has filed for bankruptcy as part of a controversial deal to settle thousands of suits over its painkiller OxyContin. (AP) The bankruptcy filing is at the center of the deal Purdue struck Wednesday to shield itself from thousands of opioid lawsuits. As part of the settlement reached with 24 states, the company...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS